Study on effect of berberine on modulating lipid and CPT I A gene expression

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 19, 2011, Pages 2715-2718

  Wang, Hong ^a   Shi, Lingyun ^a   Yin, Huafeng ^a   Zhou, Qixin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; CPT I A; Hyperlipidemia; Lipid metabolism

Indexed keywords

BERBERINE; CARNITINE PALMITOYLTRANSFERASE I; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MEVINOLIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; GENE EXPRESSION; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; MALE; MODULATION; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; BERBERINE; CARNITINE O-PALMITOYLTRANSFERASE; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GENE EXPRESSION; HUMANS; HYPERLIPIDEMIAS; LIPID METABOLISM; MALE; PPAR GAMMA; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 84855439546     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20111923     Document Type: Article

References (14)

1. Kuo C L, Chi C W, Liu T Y. The anti-inflammatory potential of berberine in vitro and in vivo[J]. Cancer Lett, 2004,203(2):127.
2. Lee D U, Kang Y J, Park M K, et al. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-alpha, iNOS, and IL-12 production in LPS-stimulated macrophages[J]. Life Sci, 2003,73(11):1401.
3. Kong W J, Wei J, Alidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins[J]. Nat Med, 2004,10(12):1344.
4. Wang C B, Lu F E, Leng S H, et al. Effects of berberine on the activity of glucokinase and the gene expression in cultured hepG2 cells[J]. Chin pharm bull, 2007,23(9):1145.
5. Ko B S, Choi S B, Park S K, et al. Insulin sensitizing and insulinotropic action of berberine from Cortidis Rhizoma[J]. Biol Pharm Bull, 2005,28(8):1431.
6. Yin J, Gao Z, Liu D, et al. Berberine improves glucose metabolism through induction of glycolysis[J]. Am J Physiol Endocrinol Metab, 2008,294:E148.
7. Savage D B, Semple R K. Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance[J]. Curr Opin Lipidol, 2010,21(4):329.
8. Kong W J, Wei J, Alidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins[J]. Nat Med, 2004,10(12):1344.
9. Akita N, Tsujita M, Yokota T, et al. High density lipoprotein turnover is dependent on peroxisome proliferator-activated receptor α in mice[J]. J Atheroscler Thromb, 2010,17(11):1149.
10. Mascaró C, Acosta E, Ortiz J A, et al. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor[J]. J Biol Chem, 1998,273:8560.
11. Stefanovic-Racic M, Perdomo G, Mantell B S, et al. A moderate increase in carnitine palmitoyltransferase-1a activitys is sufficient to substantially reduce hepatic triglyceride levels[J]. Am J Physiol Endocrinol Metab, 2008,294(5):E969.
12. Hammond L E, Gallagher P A, Wang S, et al. Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition[J]. Mol Cell Biol, 2002,22(23):8204.